Head of Business Development, Healthagen, an Aetna company
Rachel joined Aetna from the Carlyle Group where she invested in health care companies for Carlyle’s US Growth Equity Fund. Prior to the Carlyle Group, Rachel was Vice President of Business Development and a corporate officer of Datascope. Previously, she spent several years in operations and business development with Bertelsmann, a global media company. Rachel started her career at Goldman Sachs in the mergers and acquisitions and equity capital markets departments.